Related Experiment Video
Updated: Jan 8, 2026
Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice
Published on: June 11, 2020
Treatment considerations for the management of neonatal onset seizures
Jordan Burdine1, Amanda Capino2, Mandy Harlow3
1Pharmacy Department (JB), Memorial Hermann Health System, Houston, TX.
Insights
Neonatal seizures require specialized treatment guidelines due to unique causes like intraventricular hemorrhage and hypoxic ischemic encephalopathy. This article reviews pharmacological interventions for treating seizures in newborns to improve neurodevelopmental outcomes.
Area of Science:
- Neonatal neurology
- Pediatric pharmacology
Background:
- Neonates have a higher risk of seizures compared to pediatric patients.
- Seizures in neonates are often provoked by conditions such as intraventricular hemorrhage (IVH) in preterm infants and hypoxic ischemic encephalopathy (HIE) in term infants.
- Early recognition and treatment are crucial for optimal neurodevelopmental outcomes.
Purpose of the Study:
- To focus on pharmacological interventions for neonatal seizures.
- To provide an overview of treatment considerations for this specific population.
Main Methods:
- Review of clinical practice guidelines for neonatal seizures.
- Analysis of common etiologies and their impact on treatment.
- Discussion of pharmacological agents used in neonatal seizure management.
Main Results:
- Neonatal seizures are distinct from pediatric seizures and necessitate separate treatment protocols.
- IVH and HIE are leading causes of provoked seizures in preterm and term neonates, respectively.
- Pharmacological treatment is a key component in managing neonatal seizures.
Conclusions:
- Pharmacological interventions are essential for managing neonatal seizures.
- Tailored treatment strategies are necessary due to the unique pathophysiology in neonates.
- Effective management of neonatal seizures aims to mitigate long-term neurodevelopmental deficits.
Abstract:
Neonates are at an increased risk for seizures and are treated based on separate clinical practice guidelines compared with the pediatric patient population. Most seizures in the neonatal population are provoked, with the most common cause being intraventricular hemorrhage in preterm neonates and hypoxic ischemic encephalopathy in term neonates. Prompt recognition and treatment are considered cornerstones of therapy to help optimize long-term neurodevelopmental outcomes. This article focuses on considerations for pharmacological interventions in the treatment of neonatal seizures.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:14Antiepileptic Drugs: Glutamate Antagonists
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
01:13Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...